Dr. Swerdlow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4350 Shawnee Mission Pkwy
Fairway, KS 66205Phone+1 913-588-0000Fax+1 913-945-7508
Education & Training
- New York University School of MedicineClass of 1991
Certifications & Licensure
- MO State Medical License 2021 - 2026
- VA State Medical License 1994 - 2026
- KS State Medical License 2007 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Oxaloacetate Pharmacokinetics and Safety Start of enrollment: 2014 Feb 01
- S-Equol in Alzheimer's Disease (SEAD) Trial Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- RILP Cleavage Links an Inflammatory State to Enhanced Tau Propagation in a Cell Culture Model of Alzheimer's Disease.Kayla E King, Mohammad Haeri, Russell H Swerdlow, Ann L Wozniak
Molecular Biology of the Cell. 2025-03-26 - Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort.Kyan Younes, Emily Johns, Christina B Young, Gabriel Kennedy, Shubhabrata Mukherjee
Alzheimer's & Dementia. 2025-03-01 - Efficacy and Safety of Exogenous Ketones in People with Mild Neurocognitive Disorder and Alzheimer's Disease: A Systematic Literature Review.Pierre Krolak-Salmon, Russell H Swerdlow, Thibault Mastain, Catherine Dive-Pouletty, Nick Pooley
Nutrition Reviews. 2025-03-01
Press Mentions
- Regular Use of Laxatives May Increase Risk by 51%February 24th, 2023
- Regular Laxative Use Linked to Increased Dementia RiskFebruary 23rd, 2023
- Alzheimer's: Can a Blood Test Detect Disease 3.5 Years Before Diagnosis?January 31st, 2023
- Join now to see all
Grant Support
- University of Kansas Alzheimer's Disease Research Center (KU ADRC)UNIVERSITY OF KANSAS MEDICAL CENTER2021–2026
- Mechanistic Basis of the mtDNA Haplogroup J-Alzheimer's Disease AssociationUNIVERSITY OF KANSAS MEDICAL CENTER2019–2025
- Oxaloacetate'S Brain EffectsNational Institute Of Neurological Disorders And Stroke2012
- University Of Kansas Alzheimer'S Disease Core CenterNational Institute On Aging2011
- Neuropathology CoreNational Institute On Aging2011
- Neuroimaging CoreNational Institute On Aging2011
- Mitochondrial Genomics And Metabolism CoreNational Institute On Aging2011
- Education And Information Transfer CoreNational Institute On Aging2011
- Data Management And Statistics CoreNational Institute On Aging2011
- Clinical CoreNational Institute On Aging2011
- Administrative CoreNational Institute On Aging2011
- Cytochrome Oxidase Polymorphisms In AgingNational Institute On Aging2007
- Cytochrome Oxidase Polymorphisms In AgingNational Institute On Aging2005–2007
- Pathophysiology In NeurodegenerationNational Institute On Aging1998–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: